Ideas

Natural product-based Immune enhancement therapy: Vigna nakashimae extract increases SOX2 expression and promotes innate immunity against bacterial infection via down regulation of its target gene, 29/September/2016, 8.04 am

Natural product-based Immune enhancement therapy: Vigna nakashimae extract increases SOX2 expression and promotes innate immunity against bacterial infection via down regulation of its target gene, 29/September/2016, 8.04 am 150 150 Dr Boomi's Genom-2-Discovery Center

A recent study from the Institute of Biophysics, Chinese Academy of Sciences, Beijing, China shows that “Sox2 functions as a sequence-specific DNA sensor in neutrophils to initiate innate immunity against microbial infection.” This study…

read more

Molecular therapy for Myocardial Infarction: Long ncRNA-MALAT1 improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 29/September/2016, 7.47 am

Molecular therapy for Myocardial Infarction: Long ncRNA-MALAT1 improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 29/September/2016, 7.47 am 150 150 Dr Boomi's Genom-2-Discovery Center

A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the 7 March  2013 issue of Nature  by Prof Dimmler, Boon, and others. On the foundation of this…

read more

Natural product Cardiac rejuvenation therapy: Thermostable extract of fenugreek seeds inhibits dilated cardiomyopathy and heart failure via up regulation of its target gene, 28/September/2016, 10.12 pm

Natural product Cardiac rejuvenation therapy: Thermostable extract of fenugreek seeds inhibits dilated cardiomyopathy and heart failure via up regulation of its target gene, 28/September/2016, 10.12 pm 150 150 Dr Boomi's Genom-2-Discovery Center

A recent study from the Stem Cell Aging Group, Centro Nacional de Investigaciones Cardiovasculares, E-28029 Madrid, Spain shows that “Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence.” This study was published in…

read more

Molecular therapy for Myocardial Infarction: Carnosic acid (CA), isolated from Rosemary (Rosemarinus officious), improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 28/September/2016, 7.37 pm

Molecular therapy for Myocardial Infarction: Carnosic acid (CA), isolated from Rosemary (Rosemarinus officious), improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 28/September/2016, 7.37 pm 150 150 Dr Boomi's Genom-2-Discovery Center

A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the 7 March  2013 issue of Nature  by Prof Dimmler, Boon, and others. On the foundation of this…

read more

Molecular therapy for Myocardial Infarction: Long ncRNA-ADNCR improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 28/September/2016, 6.42 pm

Molecular therapy for Myocardial Infarction: Long ncRNA-ADNCR improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 28/September/2016, 6.42 pm 150 150 Dr Boomi's Genom-2-Discovery Center

A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the 7 March  2013 issue of Nature  by Prof Dimmler, Boon, and others. On the foundation of this…

read more

Anti-telomerase cancer therapy: VHL suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and inhibits cancer progression via down regulation of its target gene, 28/September/2016, 9.27 am

Anti-telomerase cancer therapy: VHL suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) and inhibits cancer progression via down regulation of its target gene, 28/September/2016, 9.27 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ The 1989 Nobel prize winner in Chemistry, Prof. Thomas R. Cech from the BioFrontiers Institute, USA has published a research paper in the 13 December 2012 Nature (492(7428):285-9; and I.F: >42) stating that “The TEL patch of telomere protein TPP1…

read more